Surveillance Testing Sample Clauses

The Surveillance Testing clause establishes requirements for ongoing or periodic testing to monitor compliance, safety, or performance standards. Typically, this clause outlines the frequency, methods, and responsible parties for conducting such tests, and may specify the types of data to be collected or reported. Its core function is to ensure continuous oversight and early detection of issues, thereby maintaining standards and mitigating risks throughout the duration of an agreement or project.
Surveillance Testing. Pursuant to their authority under Act 188, Presidents of State Universities may authorize mandatory COVID-19 testing for their residential students. Students residing on campus will be provided notice by email when any testing requirements have been enacted, modified, or withdrawn. If you reside on campus during the Spring 2021 term, you should expect to be required to undergo regular COVID-19 testing.
Surveillance Testing. The District will conduct Surveillance Testing in accordance with Table 3 of the Consolidated School Guidance.
Surveillance Testing. An independent agency designated by the programme administrator shall collect samples at the dispatch point or customers premises and get the samples tested at an independent laboratory once in a quarter. The samples shall conform to the requirements specified for the tests. In case of non-conformity, two more samples shall be tested, both of these subsequent samples shall conform to the specified requirements. The agency should draw the sufficient number of units to take care of this eventuality.
Surveillance Testing. A Westminster College employee will conduct antigen testing of unvaccinated students 3 (three) times per week on non-consecutive days.
Surveillance Testing. Ten (10) canister pairs from each production lot shall be selected by a Government representative, packaged, marked for shelf-life testing and shipped as specified in the contract.
Surveillance Testing. Orange County Public Health Lab (OCPHL) is a division within the Orange County Health Care Agency (HCA) Public Health Services (PHS) department. The Orange County Public Health Laboratory consists of a 23,000 sq. ft. main laboratory located in Santa ▇▇▇ and a separate 5,000 sq. ft. Water Quality Laboratory located in Newport Beach. OCPHL is certified by CLIA and approved by the State to perform high complexity testing in the areas of bacteriology, mycobacteriology, mycology, parasitology, virology, immunology, and molecular biology. Additionally, OCPHL has a Water Quality laboratory located in Newport Beach that is certified by the CA Environmental Laboratory Accreditation Program (ELAP) that primarily monitors the County’s ocean and bay recreational waters. OCPHL can perform diagnostic testing for diseases such as SARS-CoV-2, HIV, Measles, Influenza, Tuberculosis, and Salmonella. OCPHL participates in several year-round surveillance programs such as GISP (Gonococcal Isolate Surveillance Project), ILI (Influenza like Illness), ISP (Influenza Surveillance Program), and PulseNet for foodborne surveillance. OCPHL performs testing for: • HCA Corrections (men and women adult jail and juvenile hall) • HCA PH Clinics: Family Health, STD/HIV, Pulmonary Disease Services • Community Based Organizations (mainly HIV/STD testing) • Hospitals and Clinical laboratories • OC Animal Care (rabies) • OC Environmental Health (environmental, mainly water) • OC Public Works (water testing) OCPHL staff receive specimen requests from internal and external clients. Internal clinics submit lab requests using Cerner system while the process of matching patient information to specimen, receiving paper requests from external clients and reporting results back is not automated. There are approximately 90,000 lab requests received from internal clinics via automated transmission in a year and 38,000 requests received from external clients in a year that require paper manual process. There are 89 external clients. External clients include hospitals, clinical laboratories, community-based organizations, family health centers, nursing facilities and homeless facilities.
Surveillance Testing. This is anonymous, unlinked testing which is done in order to determine the incidence and prevalence of disease within a particular community or group to provide information to control, prevent and manage the disease.
Surveillance Testing. Bargaining unit members agree to comply with surveillance testing provided by the employer when the tests are administered during the member’s regularly scheduled work shift. Members will not experience a loss of pay during the administration of the test.
Surveillance Testing. The District will conduct Surveillance Testing in accordance with Table 3 “Testing Cadences with Support from the State of California K-12 Schools” of the Consolidated School Guidance.

Related to Surveillance Testing

  • ODUF Testing 6.6.1 Upon request from TWTC, AT&T shall send ODUF test files to TWTC. The Parties agree to review and discuss the ODUF file content and/or format. For testing of usage results, AT&T shall request that TWTC set up a production (live) file. The live test may consist of TWTC’s employees making test calls for the types of services TWTC requests on ODUF. These test calls are logged by TWTC, and the logs are provided to AT&T. These logs will be used to verify the files. Testing will be completed within thirty (30) days from the date on which the initial test file was sent.

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.

  • Stability Testing Patheon will conduct stability testing on the Products in accordance with the protocols set out in the Specifications for the separate fees and during the time periods set out in Schedule C. Patheon will not make any changes to these testing protocols without prior written approval from Client. If a confirmed stability test failure occurs, Patheon will notify Client within [***], after which Patheon and Client will jointly determine the proceedings and methods to be undertaken to investigate the cause of the failure, including which party will bear the cost of the investigation. Patheon will not be liable for these costs unless it has failed to perform the Manufacturing Services in accordance with the Specifications and cGMPs. Patheon will give Client all stability test data and results at Client’s request.

  • Inspection/Testing In order to assess Supplier’s work quality and/or compliance with this Order, upon reasonable notice by Buyer: (a) all goods, materials and services related to the items purchased hereunder, including, raw materials, components, assemblies, work in process, tools and end products shall be subject to inspection and testing by Buyer, its customer, representative or regulatory authorities at all places, including sites where the goods are made or located or the services are performed, whether at Supplier’s premises or elsewhere; and (b) all of Supplier’s facilities, books and records relating to this Order shall be subject to inspection by Buyer or its designee. If specific Buyer and/or Buyer’s customer tests, inspection and/or witness points are included in this Order, the goods shall not be shipped without an inspector’s release or a written waiver of test/inspection/witness with respect to each such point; however, Buyer shall not be permitted to unreasonably delay shipment; and Supplier shall notify Buyer in writing at least twenty (20) days prior to each of Supplier’s scheduled final and, if applicable, intermediate test/inspection/witness points. Supplier agrees to cooperate with such/audit inspection including, completing and returning questionnaires and making available its knowledgeable representatives. Buyer’s failure to inspect or test goods, materials or services or Buyer’s failure to reject or detect defects by inspection or testing shall not relieve Supplier from its warranty obligations or any of its other obligations or responsibilities under this Order. Supplier agrees to provide small business as well as minority and/or women owned business utilization and demographic data upon request.